Sabrina Yuan Email

VP, Technical Accounting and Financial Reporting . ImmunityBio

Current Roles

Employees:
655
Revenue:
$1.5M
About
Leading late-stage immunotherapy company harnessing immunogenic cell death by orchestrating both the innate (NK) and adaptive (T Cell) immune system through first-in-class immunological platforms. ImmunityBio (formerly NantCell) develops novel combinations of chemo-immune sensitizers, cell therapies, cytokines, vaccines, neoepitopes, and monoclonal antibody immunotherapies to orchestrate the NK and T Cell response for cancer and infectious diseases.
ImmunityBio Address
9920 Jefferson Blvd
Culver City, CA
United States
ImmunityBio Email

Past Companies

ImmunityBio, Inc.Vice President, Technical Accounting and Financial Reporting
ImmunityBioSenior Director, Technical Accounting and Financial Reporting
ImmunityBioDirector of Technical Accounting

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.